ENRIQUE VALENCIA: Open Payments
NPI 1851161152 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,043 in 121 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,927 · 2025 $3,043
Food & beverage: $2,949Education: $94
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $621 |
| Janssen Biotech, Inc. | 16 | $584 |
| Madrigal Pharmaceuticals | 9 | $328 |
| Ardelyx, Inc. | 10 | $288 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $214 |
| Phathom Pharmaceuticals, Inc. | 5 | $195 |
| GENZYME CORPORATION | 5 | $154 |
| Lilly USA, LLC | 8 | $145 |
| Gilead Sciences, Inc. | 6 | $116 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $108 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, IBSRELA, VOQUEZNA, ENTYVIO, DUPIXENT, SKYRIZI.
Industry payments across GA — which companies pay providers there.
